Assisted reproductive technology for men and women infected with human immunodeficiency virus type 1

Clinical Infectious Diseases

Volumn 36, Issue 2, 2003, Pages 195-200

  Al Khan, Anthony ^a   Colon, Jose ^a   Palta, Vidya ^a   Bardeguez, Arlene ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ANTIRETROVIRUS AGENT; EFAVIRENZ; HYDROXYUREA; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL INSEMINATION; CHEMOPROPHYLAXIS; CHRONIC DISEASE; CLINICAL TRIAL; DEVELOPED COUNTRY; DIABETES MELLITUS; DISEASE TRANSMISSION; FEMALE; FERTILIZATION IN VITRO; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; LIVER TOXICITY; MALE; MEDICAL SOCIETY; METABOLIC ACIDOSIS; MORBIDITY; MORTALITY; NONHUMAN; PERCEPTION; PERINATAL PERIOD; PRIORITY JOURNAL; REPRODUCTION; TECHNIQUE; TECHNOLOGY; TERATOGENICITY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES; WORLD HEALTH ORGANIZATION;

FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; LABORATORIES; MALE; OBSTETRICS; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 0037439393     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/344955     Document Type: Article

References (51)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveill Rep 2001; 13:1-41.
2. Centers for Disease Control and Prevention. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotrophic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1985; 34:721-6, 731-2.
3. Selwyn PA, Carter RJ, Schoenbaum EE, et al. Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA 1989; 261:3567-71.
4. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-60.
5. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. HIV/AIDS Treatment Information Service. 4 February 2002. Available at: http://www.aidsinfo.nih.gov/guidelines.
6. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331:1173-80.
7. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. 4 May 2001. HIV/AIDS Treatment Information Service. Available at: http://www.aidsinfo.nih.gov/guidelines.
8. Lindegren ML, Byers RH, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA 1999; 282:531-8.
9. Watts H. Management of human immunodeficiency virus infection in pregnancy. N Engl J Med 2002; 346:1879-91.
10. International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999; 340:977-87.
11. Minkoff H, Santoro N. Ethical considerations in the treatment of infertility in women with human immunodeficiency virus infection. N Engl J Med 2000; 342:1748-50.
12. Lyerly AD, Anderson J. Human immunodeficiency virus and assisted reproduction: reconsidering evidence, reframing ethics. Fertil Steril 2001; 75:843-58.
13. Committee on Ethics of the American College of Obstetricians and Gynecologists (ACOG). Human immunodeficiency virus: ethical guidelines for obstetricians and gynecologists. In: Ethics in obstetrics and gynecology. Washington, DC: ACOG, 2002:42-7.
14. Ethics Committee of the Society for Reproductive Medicine. Human immunodeficiency virus and infertility treatment. Fertil Steril 2002; 77:218-22.
15. Dorenbaum A, Cunningham CK, Gelber RD, et al. Two-dose intrapartum, newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission. International PACTG 316 Study Team. JAMA 2002; 288:189-98.
16. Mandelbrot L, Landreau-Ascare A, Rekacewicz C, et al. Lamivudinezidovudine combination for prevention of maternal-infant transmission of HIV-1. Agence Nationale de Research sur des le SIDA (ANRS) 075 Study Group. JAMA 2001; 285:2083-93.
17. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single dose nevirapine compared with zidovudine for prevention of mother to child transmission of HIV-1 in Kampala, Uganda. HIVNET 012 randomized trial. Lancet 1999; 354:795-802.
18. Cooper ER, Manhattan C, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV infected women and prevention of perinatal HIV-1 transmission. Women Infants Transmission Study Group. J Acquir Immune Defic Syndr 2002; 29:484-94.
19. Fundaro C, Genovese O, Rendell C, Tamburrini E, Salvaggio E. Myelomeningocele in a child with intrauterine exposure to efavirenz. AIDS 2002; 16:299-300.
20. Bristol-Myers Squibb. Healthcare provider important drug warning letter. 5 January 2001.
21. Cunningham CK, Chaix M, Rekacewicz C, et al. Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of Pediatric AIDS Clinical Trials Group Protocol 316. Pediatric AIDS Clinical Trials Group Protocol 316 Team. J Infect Dis 2002; 186:181-8.
22. Frenkel LM, Wagner LE, Demeter LM, et al. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1. Clin Infect Dis 1995; 20:1321-6.
23. Massad LS, Riester KA, Anastos KM, et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. J Acquir Immune Defic Syndr 1999; 21:33-41.
24. Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000; 283:74-80.
25. Staples CT, Rimland D, Dudas D. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta VA (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival. Clin Infect Dis 1999; 29:150-4.
26. Hershow RC, Riester KA, Lew J, et al. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. J Infect Dis 1997; 176:414-20.
27. Tovo P, Palumba E, Ferraris G, et al. Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children. Clin Infect Dis 1997; 25:1121-4.
28. Berenguer J, Lopez Bernaldo de Quiros JC, Ricote Clemente G. Hepatitis C in patients infected by the human immunodeficiency virus. Madrid: Ediciones, 2002.
29. National Institutes of Health Consensus Development Conference statement. Management of Hepatitis C: 2002. 10-12 June 2002. Available at: http://www.consensus.nih.gov/cons/cons.htm.
30. Schieve L, Meikle SF, Ferre C, et al. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med 2002; 346:731-7.
31. Centers for Disease Control and Prevention. HIV-1 infection and artificial insemination with processed semen. MMWR Morb Mortal Wkly Rep 1990; 39:249, 255-6.
32. Semprini AE, Levi-Setti P, Bozzo M, et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 1992; 340:1317-9.
33. Semprini A, Fiore S, Pardi G. Reproductive counseling for HIV-discordant couples. Lancet 1997; 349:1401-2.
34. Marina S, Marina F, Alcoles R, et al. Human immunodeficiency virus type 1-serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertil Steril 1998; 70:35-9.
35. Wilcox AJ, Weinburg CR, O'Connor J, et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319:189-94.
36. Society for Assisted Reproductive Technology and the American Society of Reproductive Medicine. Assisted reproductive technology in the United States: 1998 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 2002; 77:18-31.
37. Kerin JF, Kirby C, Peek J, et al. Improved conception rate after intrauterine insemination of washed spermatozoa from men with poor quality semen. Lancet 1984; 10:533-5.
38. Guzick DS, Carson SA, Coutifaris C, et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. N Engl J Med 1999; 340:177-83.
39. Grubert TA, Reindell D, Kastner R, et al. Rates of postoperative complications among human immunodeficiency virus-infected women who have undergone obstetric and gynecologic surgical procedures. Clin Infect Dis 2002; 34:822-30.
40. Hamed KA, Winters MA, Holodiny M, Katzenstein DA, Merigan TC. Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy. J Infect Dis 1993; 167:798-802.
41. Krieger JN, Coombs RW, Collier AC, et al. Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiretroviral chemotherapy. J Infect Dis 1991; 163:386-8.
42. Bagasra O, Farzadegan H, Seshamma T, Oakes JW, Saah A, Pomerantz RJ. Detection of HIV-1 proviral DNA in sperm from HIV-1 infected men. AIDS 1994; 8:1669-74.
43. Van Voorhis B, Martinez A, Mayer K, Anderson DJ. Detection of human immunodeficiency virus type 1 in semen from seropositive men using culture and polymerase chain reaction deoxyribonucleic acid amplification techniques. Fertil Steril 1991; 55:588-94.
44. Zhang H, Dornadula G, Beumont M, et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998; 339:1803-9.
45. Anderson DJ, Politch JA, Oneta M, Tucker L, Semprini AE. Efficacy of conventional semen processing techniques in separation of motile sperm from HIV-1 and HIV-1 host cells [abstract P-213]. Program supplement of the 48th annual meeting of the American Fertility Society. Fertil Steril 1992:S107-8.
46. Chrystie IL, Mullen JE, Braude PR, et al. Assisted conception in HIV discordant couples: evaluation of semen processing techniques in reducing HIV viral load. J Reprod Immunol 1998; 41:301-6.
47. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41(RR-17):1-19.
48. Marina S, Marina F, Alcolea R, Nadal J, Exposito R, Huguet J. Pregnancy following intracytoplasmic sperm injection from an HIV-1-seropositive man. Hum Reprod 1998; 13:3247-9.
49. Politch JA, Xu C, Tucker L, Anderson DJ. Separation of HIV-1 from the motile sperm fraction: comparison of gradient/swim-up and double tube techniques [abstract O-130]. Fertil Steril 2001; 76(Suppl 1):S49-50.
50. American Fertility Society. Guidelines for human embryology and andrology laboratories. Fertil Steril 1992; 58(Suppl 1):S1-16.
51. Tedder RS, Zuckerman MA, Goldstone AH, et al. Hepatitis B transmission from contaminated cryopreservation tank. Lancet 1995; 346: 137-40.